Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Science 19 July 2002:
Vol. 297. no. 5580, pp. 403 - 405
DOI: 10.1126/science.1073354

Reports

Enhanced CpG Mutability and Tumorigenesis in MBD4-Deficient Mice

Catherine B. Millar,1* Jacky Guy,1* Owen J. Sansom,2* Jim Selfridge,1 Eilidh MacDougall,1 Brian Hendrich,1 Peter D. Keightley,3 Stefan M. Bishop,2 Alan R. Clarke,2 Adrian Bird1dagger

The mammalian protein MBD4 contains a methyl-CpG binding domain and can enzymatically remove thymine (T) or uracil (U) from a mismatched CpG site in vitro. These properties suggest that MBD4 might function in vivo to minimize the mutability of 5-methylcytosine by removing its deamination product from DNA. We tested this hypothesis by analyzing Mbd4-/- mice and found that the frequency of of C rightarrow  T transitions at CpG sites was increased by a factor of three. On a cancer-susceptible ApcMin/+ background, Mbd4-/- mice showed accelerated tumor formation with CpG rightarrow  TpG mutations in the Apc gene. Thus MBD4 suppresses CpG mutability and tumorigenesis in vivo.

1 Wellcome Trust Centre for Cell Biology, The King's Buildings, Edinburgh University, Edinburgh EH9 3JR, UK.
2 Cardiff School of Biosciences, Cardiff University, Post Office Box 911, Cardiff CF10 3US, UK.
3 Institute of Cell Animal and Population Biology, The King's Buildings, Edinburgh University, Edinburgh EH9 3JT, UK.
*   These authors contributed equally to this work.

dagger    To whom correspondence should be addressed. E-mail: a.bird{at}ed.ac.uk


Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Enhanced gene repair mediated by methyl-CpG-modified single-stranded oligonucleotides.
C. Bertoni, A. Rustagi, and T. A. Rando (2009)
Nucleic Acids Res.
   Abstract »    Full Text »    PDF »
High Resolution Mapping of Cia3: A Common Arthritis Quantitative Trait Loci in Different Species.
X. Yu, H. Teng, A. Marques, F. Ashgari, and S. M. Ibrahim (2009)
J. Immunol. 182, 3016-3023
   Abstract »    Full Text »    PDF »
Coordinating the Initial Steps of Base Excision Repair: APURINIC/APYRIMIDINIC ENDONUCLEASE 1 ACTIVELY STIMULATES THYMINE DNA GLYCOSYLASE BY DISRUPTING THE PRODUCT COMPLEX.
M. E. Fitzgerald and A. C. Drohat (2008)
J. Biol. Chem. 283, 32680-32690
   Abstract »    Full Text »    PDF »
Crystal structure of human thymine DNA glycosylase bound to DNA elucidates sequence-specific mismatch recognition.
A. Maiti, M. T. Morgan, E. Pozharski, and A. C. Drohat (2008)
PNAS 105, 8890-8895
   Abstract »    Full Text »    PDF »
Giving APCmin tumours a SPARC.
A. Gregorieff and H. Clevers (2007)
Gut 56, 1341-1343
   Full Text »    PDF »
Differentiation of core promoter architecture between plants and mammals revealed by LDSS analysis.
Y. Y. Yamamoto, H. Ichida, T. Abe, Y. Suzuki, S. Sugano, and J. Obokata (2007)
Nucleic Acids Res. 35, 6219-6226
   Abstract »    Full Text »    PDF »
Excision of 5-Halogenated Uracils by Human Thymine DNA Glycosylase: ROBUST ACTIVITY FOR DNA CONTEXTS OTHER THAN CpG.
M. T. Morgan, M. T. Bennett, and A. C. Drohat (2007)
J. Biol. Chem. 282, 27578-27586
   Abstract »    Full Text »    PDF »
Association of Dnmt3a and thymine DNA glycosylase links DNA methylation with base-excision repair.
Y.-Q. Li, P.-Z. Zhou, X.-D. Zheng, C. P. Walsh, and G.-L. Xu (2007)
Nucleic Acids Res. 35, 390-400
   Abstract »    Full Text »    PDF »
The DNA N-Glycosylase MED1 Exhibits Preference for Halogenated Pyrimidines and Is Involved in the Cytotoxicity of 5-Iododeoxyuridine..
D. P. Turner, S. Cortellino, J. E. Schupp, E. Caretti, T. Loh, T. J. Kinsella, and A. Bellacosa (2006)
Cancer Res. 66, 7686-7693
   Abstract »    Full Text »    PDF »
MBD family proteins: reading the epigenetic code..
M. Fatemi and P. A. Wade (2006)
J. Cell Sci. 119, 3033-3037
   Abstract »    Full Text »    PDF »
Active cytosine demethylation triggered by a nuclear receptor involves DNA strand breaks.
C. Kress, H. Thomassin, and T. Grange (2006)
PNAS 103, 11112-11117
   Abstract »    Full Text »    PDF »
Inhibitors of differentiation (ID1, ID2, ID3 and ID4) genes are neuronal targets of MeCP2 that are elevated in Rett syndrome.
S. Peddada, D. H. Yasui, and J. M. LaSalle (2006)
Hum. Mol. Genet. 15, 2003-2014
   Abstract »    Full Text »    PDF »
Kaiso-Deficient Mice Show Resistance to Intestinal Cancer.
A. Prokhortchouk, O. Sansom, J. Selfridge, I. M. Caballero, S. Salozhin, D. Aithozhina, L. Cerchietti, F. G. Meng, L. H. Augenlicht, J. M. Mariadason, et al. (2006)
Mol. Cell. Biol. 26, 199-208
   Abstract »    Full Text »    PDF »
The Thymine DNA Glycosylase MBD4 Represses Transcription and Is Associated with Methylated p16INK4a and hMLH1 Genes.
E. Kondo, Z. Gu, A. Horii, and S. Fukushige (2005)
Mol. Cell. Biol. 25, 4388-4396
   Abstract »    Full Text »    PDF »
Activation-induced Cytidine Deaminase Deaminates 5-Methylcytosine in DNA and Is Expressed in Pluripotent Tissues: IMPLICATIONS FOR EPIGENETIC REPROGRAMMING.
H. D. Morgan, W. Dean, H. A. Coker, W. Reik, and S. K. Petersen-Mahrt (2004)
J. Biol. Chem. 279, 52353-52360
   Abstract »    Full Text »    PDF »
Components of the DNA Methylation System of Chromatin Control Are RNA-binding Proteins.
L. Jeffery and S. Nakielny (2004)
J. Biol. Chem. 279, 49479-49487
   Abstract »    Full Text »    PDF »
Identification of Genetic Variants in Base Excision Repair Pathway and Their Associations with Risk of Esophageal Squamous Cell Carcinoma.
B. Hao, H. Wang, K. Zhou, Y. Li, X. Chen, G. Zhou, Y. Zhu, X. Miao, W. Tan, Q. Wei, et al. (2004)
Cancer Res. 64, 4378-4384
   Abstract »    Full Text »    PDF »
Rett Syndrome: A Prototypical Neurodevelopmental Disorder.
J. L. Neul and H. Y. Zoghbi (2004)
Neuroscientist 10, 118-128
   Abstract »    PDF »
Role of Human Ribosomal RNA (rRNA) Promoter Methylation and of Methyl-CpG-binding Protein MBD2 in the Suppression of rRNA Gene Expression.
K. Ghoshal, S. Majumder, J. Datta, T. Motiwala, S. Bai, S. M. Sharma, W. Frankel, and S. T. Jacob (2004)
J. Biol. Chem. 279, 6783-6793
   Abstract »    Full Text »    PDF »
Reading the DNA Methylation Signal.
A. BIRD and D. MACLEOD (2004)
Cold Spring Harb Symp Quant Biol 69, 113-118
   Abstract »    PDF »
MED1: A central molecule for maintenance of genome integrity and response to DNA damage.
B. L. Parsons (2003)
PNAS 100, 14601-14602
   Full Text »    PDF »
From The Cover: The base excision repair enzyme MED1 mediates DNA damage response to antitumor drugs and is associated with mismatch repair system integrity.
S. Cortellino, D. Turner, V. Masciullo, F. Schepis, D. Albino, R. Daniel, A. M. Skalka, N. J. Meropol, C. Alberti, L. Larue, et al. (2003)
PNAS 100, 15071-15076
   Abstract »    Full Text »    PDF »
Mice lacking methyl-CpG binding protein 1 have deficits in adult neurogenesis and hippocampal function.
X. Zhao, T. Ueba, B. R. Christie, B. Barkho, M. J. McConnell, K. Nakashima, E. S. Lein, B. D. Eadie, A. R. Willhoite, A. R. Muotri, et al. (2003)
PNAS 100, 6777-6782
   Abstract »    Full Text »    PDF »
Fas-associated death domain protein interacts with methyl-CpG binding domain protein 4: A potential link between genome surveillance and apoptosis.
R. A. Screaton, S. Kiessling, O. J. Sansom, C. B. Millar, K. Maddison, A. Bird, A. R. Clarke, and S. M. Frisch (2003)
PNAS 100, 5211-5216
   Abstract »    Full Text »    PDF »
Cutting Edge: The G-U Mismatch Glycosylase Methyl-CpG Binding Domain 4 Is Dispensable for Somatic Hypermutation and Class Switch Recombination.
P. D. Bardwell, A. Martin, E. Wong, Z. Li, W. Edelmann, and M. D. Scharff (2003)
J. Immunol. 170, 1620-1624
   Abstract »    Full Text »    PDF »
Mismatch Repair in Methylated DNA. STRUCTURE AND ACTIVITY OF THE MISMATCH-SPECIFIC THYMINE GLYCOSYLASE DOMAIN OF METHYL-CpG-BINDING PROTEIN MBD4.
P. Wu, C. Qiu, A. Sohail, X. Zhang, A. S. Bhagwat, and X. Cheng (2003)
J. Biol. Chem. 278, 5285-5291
   Abstract »    Full Text »    PDF »
Mbd4 inactivation increases Cright-arrowT transition mutations and promotes gastrointestinal tumor formation.
E. Wong, K. Yang, M. Kuraguchi, U. Werling, E. Avdievich, K. Fan, M. Fazzari, B. Jin, A. M. C. Brown, M. Lipkin, et al. (2002)
PNAS 99, 14937-14942
   Abstract »    Full Text »    PDF »



To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)